Miromatrix Medical

Miromatrix Medical

Signal active

Organization

Contact Information

Overview

Miromatrix Medical is a biotechnology company engaged in the development of fully biological human organs and organ-derived biological products to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization or recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care.

It was founded in 2009 and is based in Eden Prairie, Minnesota.

About

Industries

Biotechnology, Health Care, Medical, Medical Device

Founded

2009

Employees

1001-5000

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Miromatrix Medical headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Medical Device sector. The company focuses on Biotechnology and has secured $10.3B in funding across 144 round(s). With a team of 1001-5000 employees, Miromatrix Medical is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Miromatrix Medical, raised $5.3M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Doris Taylor

Doris Taylor

Founder

Funding Rounds

Funding rounds

9

Investors

1

Lead Investors

0

Total Funding Amount

$71.5M

Details

3

Miromatrix Medical has raised a total of $71.5M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2018Early Stage Venture15.7M
2021Late Stage Venture
2015Early Stage Venture23.3M

Investors

Miromatrix Medical is funded by 5 investors.

Investor NameLead InvestorFunding RoundPartners
Miromatrix Medical-FUNDING ROUND - Miromatrix Medicalundefined
CareDx-FUNDING ROUND - CareDxundefined
Miromatrix Medical-FUNDING ROUND - Miromatrix Medical1.0M
National Science Foundation-FUNDING ROUND - National Science Foundation1.0M

Recent Activity

There is no recent news or activity for this profile.